Pro DEX price to free cash flow PDEX

Market value divided by free cash flow over the last twelve months, since 2015.

Today, Oct 23, 2026: 29.5×
10-year median: 21.7×
Against its 10-year history: 70th; percentile: 0 is its lowest day, 100 its highest
10-year range: 7.8× to 63.2×
Peer median: 11.0×

Pro DEX's price to free cash flow is 29.5× as of Oct 23, 2026.

That is above its ten-year median of 21.7×, higher than on 70% of days in the last ten years.

Over that time it ranged from 7.8× in Feb 2018 to 63.2× in Dec 2020.

The median for 10 medical instruments and supplies stocks of a similar size is 11.0×.

Price to free cash flow over time

median 21.7×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	29.5×	27.6×	34.8×
2025	n/m a value too high to mean anything
2024	n/m a value too high to mean anything
2023	14.2×	14.1×	14.2×
2022	n/m a value too high to mean anything
2021	37.6×	30.1×	48.0×
2020	45.9×	16.9×	63.2×
2019	25.2×	13.7×	44.0×
2018	36.6×	7.8×	43.1×
2017	8.3×	8.1×	23.1×
2016	n/m a value too high to mean anything
2015	25.3×	24.8×	29.8×

Against its peers

Companies in Medical - Instruments & Supplies nearest Pro DEX's size, closest first, today.

Company	Price to free cash flow
PDEXPro DEX	29.5×
UTMDUtah Medical Products	20.6×
INFUInfuSystem	12.1×
EMBCEmbecta	2.3×
KEQUKewaunee Scientific	8.7×
TCMDTactile Systems Technology	20.0×
MDXGMimedx	n/m
APTAlpha Pro Tech	9.7×
MOVMovado	9.8×
NEPHNephros	n/m
IRMDIradimed	43.7×
Peer median	11.0×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Pro DEX

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.